Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Mereo Biopharma Group Plc ADR (NASDAQ: MREO) was $0.38 for the day, down -8.87% from the previous closing price of $0.42. In other words, the price has decreased by -$8.87 from its previous closing price. On the day, 21.75 million shares were traded. MREO stock price reached its highest trading level at $0.4179 during the session, while it also had its lowest trading level at $0.3511.
Ratios:
Our analysis of MREO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.71 and its Current Ratio is at 8.71. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 27, 2025, JP Morgan started tracking the stock assigning a Overweight rating and target price of $7.
On December 06, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $7.Jefferies initiated its Buy rating on December 06, 2024, with a $7 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MREO now has a Market Capitalization of 61170224 and an Enterprise Value of 257550128. For the stock, the TTM Price-to-Sale (P/S) ratio is 119.92 while its Price-to-Book (P/B) ratio in mrq is 1.31. Its current Enterprise Value per Revenue stands at 515.1 whereas that against EBITDA is -5.72.
Stock Price History:
The Beta on a monthly basis for MREO is 0.31, which has changed by -0.88112676 over the last 52 weeks, in comparison to a change of 0.1877265 over the same period for the S&P500. Over the past 52 weeks, MREO has reached a high of $3.84, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -77.49%, while the 200-Day Moving Average is calculated to be -80.94%.
Shares Statistics:
MREO traded an average of 9.98M shares per day over the past three months and 52925060 shares per day over the past ten days. A total of 159.10M shares are outstanding, with a floating share count of 137.51M. Insiders hold about 13.57% of the company’s shares, while institutions hold 62.50% stake in the company. Shares short for MREO as of 1765756800 were 9785445 with a Short Ratio of 0.98, compared to 1763078400 on 9249501. Therefore, it implies a Short% of Shares Outstanding of 9785445 and a Short% of Float of 8.649999999999999.
Earnings Estimates
The performance of Mereo Biopharma Group Plc ADR (MREO) in the stock market is under the watchful eye of 6.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $0.0, with high estimates of $0.03 and low estimates of -$0.01.
Analysts are recommending an EPS of between -$0.04 and -$0.05 for the fiscal current year, implying an average EPS of -$0.04. EPS for the following year is -$0.03, with 5.0 analysts recommending between $0.03 and -$0.04.
